zentiva group

Private

Last Round

Buyout/LBO

Sep 11, 2025

Last Round Size

$2.1B

Est. Valuation

$2.1B

Total Funding Raised

$2.1B

Company Overview

Developer, manufacturer, and marketer of a wide range of generic and over-the-counter (OTC) pharmaceutical products.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare zentiva group with similar companies based on industry and business-model similarity.

Access detailed peer comparisons, similarity scores, and market data.

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	Sep 11, 2025
Buyout/LBO	Oct 1, 2018

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about zentiva group's valuation, stock price, and market status.

Headquarters—

Year Founded1993

Last FundingSep 11, 2025

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.